NDC 63629-2019-01 - Meloxicam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-2019
- Requested NDC
- 63629-2019-01
- Package NDCs from labels
- 63629-2019-1, 63629-2019-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2025-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Meloxicam - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-2019-1 | Meloxicam | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 103 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-2019 | MELOXICAM TABLET [BRYANT RANCH PREPACK] | 103 | Current NDC, Legacy NDC, 1 package rows | 20250322_218e71c6-265a-45f4-b660-5c1da5a36bd2.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-2019-1 | EA - Each | 63629-2019 | 98bb0f2d-b773-453c-b5bb-cacc6dc1f540 | 1 | 2021-03-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 218e71c6-265a-45f4-b660-5c1da5a36bd2 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | ANDA077918 63629-2019-1 63629-2019 63629201901 152695 9939f5cb-7831-4adf-a554-35318bf2d8a1 218e71c6-265a-45f4-b660-5c1da5a36bd2 VG2QF83CGL |
| Meloxicam | MELOXICAM | Aurobindo Pharma Limited | d5e12448-1ca1-46a4-8de4-e8b94567e5a8 | 2025-03-15 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | 1Q73Q2JULR |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| MELOXICAM | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 2eaac8b2-d50a-a0bc-e063-6294a90a7cac | 2025-02-21 | Boxed warning, Warnings, Adverse reactions | 311486 VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | 29974b41-68b4-42cf-8835-18ae480c2952 | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | 311486 VG2QF83CGL |
| Dairy-Grain-Nightshades | IRIS VERS., SOLIDAGO, ANTIMON. CRUD., ARG. NIT., ARSENICUM ALB., AVENA, BAPTISIA, BELLADONNA, BRYONIA, CAPSICUM, CARDUUS BEN., CINCHONA, DULCAMARA, FAGOPYRUM, GELSEMIUM, HYOSCYAMUS, IPECAC., LAC VAC., LACHESIS, LYCOPODIUM, NAT. MUR., PHOS., PODOPH. PELT., PULSATILLA, RHUS TOX., SAC. LAC., SECALE, SEPIA, STRAMONIUM, TABACUM, TRITICUM, USTILAGO MAIDIS, VERBASCUM, LYCOPERSICUM, SOLANUM NIG., SOLANUM TUB., STIGMATA, TORULA CEREVISIAE. | Newton Laboratories, Inc. | 9ba83c60-35be-181a-e053-2a95a90a9895 | 2025-02-06 | Warnings | J2B2A4N98G |
| meloxicam | MELOXICAM | Asclemed USA, Inc. | 4dc34489-cbb6-4e57-a2cc-a274209456f3 | 2025-02-06 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Anticoagulant Citrate Dextrose A ACD-A | ANTICOAGULANT CITRATE DEXTROSE A ACD-A | Arteriocyte Medical Systems, Inc. | b850deac-161f-4bb0-ac7f-bceac2a230c0 | 2025-01-23 | 1Q73Q2JULR | |
| ACD A | DEXTROSE MONOHYDRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | Terumo BCT Ltd | 570770de-9b48-4fc1-a1ee-06002ca9504f | 2025-01-22 | 1Q73Q2JULR | |
| Anticoagulant Citrate Dextrose (ACD-A) | DEXTROSE MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, AND CITRIC ACID MONOHYDRATE | Terumo BCT, Ltd | 0130d7c8-d067-4528-beb7-166559c33be9 | 2025-01-21 | Warnings, Adverse reactions | 1Q73Q2JULR |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | AvPAK | fe070e2e-3e72-fb84-e053-6294a90afd88 | 2025-01-09 | Adverse reactions | 1Q73Q2JULR |
| MELOXICAM | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 25b742d8-5a95-9ec8-e063-6294a90a89ae | 2025-01-03 | Boxed warning, Warnings, Adverse reactions | 311486 152695 VG2QF83CGL |
| meloxicam | MELOXICAM | PD-Rx Pharmaceuticals, Inc. | 4acea0aa-973f-40e5-88b4-0e2d85ea624c | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 311486 VG2QF83CGL |
| meloxicam | MELOXICAM | Preferred Pharmaceuticals Inc. | ef3447a9-ed6a-4cba-9681-09ae9dc8b630 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | af9cf496-d505-f2ba-e053-2995a90a76cf | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 311486 VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | af9d0426-9cbb-a6a3-e053-2995a90aed2f | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 311486 VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | af9cde70-6c74-f6a8-e053-2995a90addaf | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | af9cb78a-e61b-b099-e053-2a95a90a3ad8 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | b33bf17a-3134-6f32-e053-2a95a90a261b | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 152695 VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.